Past infections may shape your COVID booster’s punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

Vita 34 stabilizes business development in the second quarter and noticeably improves earnings – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): Half Year Results Vita 34 stabilizes business development in the second quarter and noticeably improves earnings 31.08.2023 /

September 1, 2023

Genespire raises $52m in Series B to trial paediatric gene therapy

Genespire’s GENE202 was developed using the company’s Immune Shielded Lentiviral Vector (ISLV) platform that allows a patient’s liver to produce the therapy throughout its lifetime.

September 25, 2024

Eli Lilly’s Prevail strikes potential billion-dollar AAV capsids deal with Sangamo for neurological diseases

Eli Lilly’s Prevail Therapeutics has expanded again into neurological targets thanks to a potential billion-dollar deal with Sangamo Therapeutics. The pair will evaluate some of

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.